Dr. Maryam Fouladi, MD
Claim this profileNationwide Children's Hospital
Area of expertise
Brain Tumor
Maryam Fouladi, MD has run 14 trials for Brain Tumor. Some of their research focus areas include:
Diffuse Intrinsic Pontine Glioma
Maryam Fouladi, MD has run 9 trials for Diffuse Intrinsic Pontine Glioma. Some of their research focus areas include:
Affiliated Hospitals
Nationwide Children's Hospital
Cincinnati Children Hospital Medical Center
Clinical Trials Maryam Fouladi, MD is currently running
Ribociclib + Everolimus
for Brain Tumors
This trial is testing whether the combination of ribociclib and everolimus can help children and young adults with aggressive brain tumors live longer. Everolimus is a medication that has been approved for treating various cancers. These drugs are taken by mouth and work by stopping cancer cells from growing. The study focuses on patients whose tumors have specific genetic changes that make them hard to treat with standard therapies.
Recruiting
1 award
Phase 2
PEP-CMV Vaccine
for Pediatric Brain Tumor
This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with newly-diagnosed high-grade glioma (HGG) or diffuse intrinsic pontine glioma (DIPG) as well as recurrent medulloblastoma (MB). PEP-CMV is a vaccine mixture of a peptide referred to as Component A. Component A is a synthetic long peptide (SLP) of 26 amino acid residues from human pp65. The SLPs encode multiple potential class I, class II, and antibody epitopes across several haplotypes. Component A will be administered as a stable water:oil emulsion in Montanide ISA 51. Funding Source - FDA OOPD
Recruiting
1 award
Phase 2
More about Maryam Fouladi, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Maryam Fouladi, MD has experience with
- PEP-CMV Vaccine
- Tocilizumab
- Everolimus
- Ribociclib
- Lorlatinib
- Temozolomide
Breakdown of trials Maryam Fouladi, MD has run
Diffuse Intrinsic Pontine Glioma
Brain Cancer
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maryam Fouladi, MD specialize in?
Maryam Fouladi, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved NTRK positive patients, or patients who are H3 K27M positive.
Is Maryam Fouladi, MD currently recruiting for clinical trials?
Yes, Maryam Fouladi, MD is currently recruiting for 6 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Maryam Fouladi, MD has studied deeply?
Yes, Maryam Fouladi, MD has studied treatments such as PEP-CMV Vaccine, Tocilizumab, Everolimus.
What is the best way to schedule an appointment with Maryam Fouladi, MD?
Apply for one of the trials that Maryam Fouladi, MD is conducting.
What is the office address of Maryam Fouladi, MD?
The office of Maryam Fouladi, MD is located at: Nationwide Children's Hospital, Columbus, Ohio 43235 United States. This is the address for their practice at the Nationwide Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.